Theratechnologies Inc. (TSE:TH – Get Free Report)’s stock price traded up 1.9% during trading on Thursday . The company traded as high as C$2.21 and last traded at C$2.18. 37,126 shares changed hands during trading, a decline of 12% from the average session volume of 42,232 shares. The stock had previously closed at C$2.14.
Theratechnologies Trading Down 5.7 %
The company has a current ratio of 1.10, a quick ratio of 0.64 and a debt-to-equity ratio of 562.07. The company has a market cap of C$105.75 million, a price-to-earnings ratio of -12.78, a price-to-earnings-growth ratio of -8.50 and a beta of 1.73. The firm has a 50-day moving average price of C$2.39 and a 200 day moving average price of C$1.98.
Theratechnologies Company Profile
Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.
Further Reading
- Five stocks we like better than Theratechnologies
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Why New Tariffs Could Boost These 3 Basic Materials Stocks
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- MarketBeat Week in Review – 02/03 – 02/07
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Meta Platforms Continues to Prove Why It’s a Premier Play on AI
Receive News & Ratings for Theratechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies and related companies with MarketBeat.com's FREE daily email newsletter.
